This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Tel Aviv University. Active years: 2020-2021.
Company Filing History:
Years Active: 2020-2021
Title: The Innovations of Hagit Eiger
Introduction
Hagit Eiger is a notable inventor based in Hadera, Israel. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that target aggregation-prone proteins. With a total of 2 patents, Eiger's work is paving the way for new treatments for various diseases.
Latest Patents
Eiger's latest patents focus on PERK inhibitors and their uses in treating diseases associated with aggregation-prone proteins. The compounds represented by Formula I are disclosed, wherein R, Ra, and R' are defined. These patents detail methods for utilizing these compounds to inhibit the activity of PERK, which is crucial in treating diseases where downregulating the unfolded protein response is beneficial, including Huntington's disease.
Career Highlights
Hagit Eiger is affiliated with Tel Aviv University, where he conducts his research and development. His work has garnered attention for its potential impact on therapeutic strategies for neurodegenerative diseases. Eiger's innovative approach combines biochemistry with practical applications in medicine.
Collaborations
Eiger collaborates with esteemed colleagues, including Gerardo Zelmar Lederkremer and Julia Leitman. Their combined expertise enhances the research efforts and contributes to the advancement of their projects.
Conclusion
Hagit Eiger's contributions to the field of biochemistry through his patents on PERK inhibitors highlight his role as an influential inventor. His work not only showcases innovation but also holds promise for future medical advancements.